Drugs Health Pharma

Roche, Alnylam to jointly develop hypertension therapy

HQ Team July 25, 2023: Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to.

Read More
Drugs Pharma

Roche’s Alzheimer’s drug fails to meet primary target

Roche, a Swiss drugmaker, announced its Alzheimer's drug did not meet the primary goal of slowing the disease during two clinical trials

Read More
X